Steinberg Andrew P, Kilciler Mete, Abreu Sidney C, Ramani Anup P, Ng Christopher, Desai Mihir M, Kaouk Jihad H, Gill Inderbir S
Section of Laparoscopic and Minimally Invasive Surgery, Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Urology. 2004 Aug;64(2):255-8. doi: 10.1016/j.urology.2004.03.030.
To review our experience with laparoscopic nephron-sparing surgery in the management of two or more synchronous, ipsilateral renal masses. Minimally invasive nephron-sparing procedures are increasingly used for the treatment of select patients with a single, small renal tumor.
Since 1998, we have performed laparoscopic nephron-sparing surgery in 288 consecutive patients, including laparoscopic partial nephrectomy (n = 200) and renal cryotherapy (n = 88). Of these, 13 patients (4.5%) were treated for synchronous ipsilateral renal masses.
A total of 27 renal tumors were treated in 13 patients. The patients were divided into four groups on the basis of the treatment. Group 1 (n = 3) underwent en-bloc laparoscopic partial nephrectomy encompassing both tumors; group 2 (n = 2) underwent individual laparoscopic partial nephrectomy of discrete masses during the same procedure; group 3 (n = 2) had one mass treated with partial nephrectomy and the other mass treated with cryotherapy; and group 4 (n = 6) had all tumors treated with cryotherapy. All cases were completed successfully without conversion to open surgery or laparoscopic nephrectomy. The mean overall operative time was 4.3 hours, and the mean blood loss was 169 mL. No intraoperative complications occurred. Three patients had postoperative complications, none requiring re-exploration. One patient in group 4 developed de novo tumors in the treated kidney, located distant from the cryoablated sites.
Laparoscopic partial nephrectomy is an emerging, efficacious laparoscopic treatment option for select patients. Laparoscopic cryotherapy is a useful alternative or adjunct to partial nephrectomy. The judicious combination of these complementary techniques further extends the scope of minimally invasive nephron-sparing surgery.
回顾我们运用腹腔镜保留肾单位手术治疗两个或更多同侧同步肾肿块的经验。微创保留肾单位手术越来越多地用于治疗特定的单发小肾肿瘤患者。
自1998年以来,我们连续对288例患者实施了腹腔镜保留肾单位手术,包括腹腔镜部分肾切除术(n = 200)和肾冷冻消融术(n = 88)。其中,13例(4.5%)患者接受了同侧同步肾肿块的治疗。
13例患者共治疗了27个肾肿瘤。根据治疗方法将患者分为四组。第1组(n = 3)接受了包括两个肿瘤的整块腹腔镜部分肾切除术;第2组(n = 2)在同一手术过程中对离散肿块进行了单独的腹腔镜部分肾切除术;第3组(n = 2)一个肿块采用部分肾切除术治疗,另一个肿块采用冷冻消融术治疗;第4组(n = 6)所有肿瘤均采用冷冻消融术治疗。所有病例均成功完成,未转为开放手术或腹腔镜肾切除术。平均总手术时间为4.3小时,平均失血量为169毫升。术中无并发症发生。3例患者出现术后并发症,均无需再次探查。第4组中有1例患者在治疗的肾脏中出现了新生肿瘤,位于远离冷冻消融部位的地方。
腹腔镜部分肾切除术是一种适用于特定患者的新兴、有效的腹腔镜治疗选择。腹腔镜冷冻消融术是部分肾切除术的一种有用替代方法或辅助手段。这些互补技术的合理组合进一步扩大了微创保留肾单位手术的范围。